Platinum Open Access

Swiss Medical Weekly, which began publication in 1871 as “Correspondenz-Blatt für Schweizer Aerzte”, is an international peer-reviewed medical journal following the Platinum Open Access model. Platinum Open Access means that the articles are published fully open access and that the journal does not charge any APCs (article-processing charges).

The "Swiss Medical Weekly" is supported by the Swiss Academy of Medical Sciences (SAMS) and the Swiss Medical Association (FMH).

The quality of SMW publications is guaranteed by a consistent policy of rigorous single-blind peer review. All editorial decisions are made by research-active academics. The large number of reviews fills its pages with a wide range of cutting edge but also established themes.

The Swiss Medical Weekly is the official scientific publication of the Swiss Society of General Internal Medicine, the Swiss Society of Infectiology, the Swiss Society of Rheumatology and the Swiss Society of Pulmonary Hypertension.

Previous titles:

Correspondenz-Blatt für Schweizer Aerzte (1871-1919)

Schweizerische Medizinische Wochenschrift / Journal Suisse de Médecine (Schweiz Med Wochenschr) (1920-2000)

The Swiss Medical Weekly has played a decisive role in Swiss clinical research.

Discover topics from the early years


Swiss Medical Weekly in "Dimensions": most cited articles

Swiss Medical Weekly in "Google Scholar": h5 index = 33

Editorial board

Prof. Dr. med. Adriano Aguzzi
Editor in chief

Institute Director, Institute of Neuropathology, UniversitätsSpital Zürich, Switzerland

Prof. Dr. med. Manuel Battegay
Deputy editor in chief

Chief of the Division for Infectious Diseases and Hospital Epidemiology, University Hospital, Basel, Switzerland

Prof. Dr. med. Jean-Michel Dayer

Emeritus Professor of Medicine of the University of Geneva, Switzerland

Prof. Dr. med. Christian Seiler, MHA, FACS

Co-chairman of cardiology at the University Hospital, Bern, Switzerland

Prof. Dr. med. André P. Perruchoud
Senior editor

Emeritus Professor of Medicine of the University of Basel, Switzerland

Prof. Dr. med. Peter Suter
Senior editor

Emeritus Professor of Medicine of the University of Geneva, Switzerland

Your contacts in the editing company

Natalie Marty, MD
Head of publications

e-mail: Natalie Marty
tel. +41 (0)61 467 85 50

Katharina Blatter, Dr. phil.
Managing editor

e-mail: Katharina Blatter
Tel. +41 (0)61 467 85 25

Eveline Maegli
Editorial office

e-mail: Eveline Maegli
tel. +41 (0)61 467 85 52


Swiss Medical Weekly

Mode of publication: continuous online publication

ISSN: 1424-3997

Title abbreviation: Swiss Med Wkly

Abstracted/indexed in Index Medicus / MEDLINE; Dimensions; Current Contents / Science Citation Index; EMBASE

Formerly: Schweizerische medizinische Wochenschrift (1920-2000, ISSN: 0036-7672, eISSN 1424-3997) and Correspondenz-Blatt für Schweizer Ärzte (1871-1919, ISSN 0366-5461)

Picture credits: please click here

Editing company

EMH Swiss Medical Publishers Ltd.
Farnsburgerstrasse 8
CH-4132 Muttenz
Tel. +41 (0)61 467 85 55
Fax +41 (0)61 467 85 56
e-mail: EMH

Dr. med. et lic. phil. Bruno Kesseli

Editor in chief Swiss Medical Journal
e-mail: Bruno Kesseli
Tel. +41 (0)61 467 85 51

Dr. phil. II Karin Würz

Manager of marketing and communication
e-mail: Karin Würz
Tel. +41 (0)61 467 85 49

Dr. med. Natalie Marty

Head of publications
e-mail: Natalie Marty
Tel. +41 (0)61 467 85 50

Dr. Sandra Ziegler

Managing director
e-mail: Sandra Ziegler
Tel. +41 (0)61 467 85 89

Open access license

"Swiss Medical Weekly" is an open access publication of EMH published in accordance with the terms of the Creative Commons licence attribution - NonCommercial - NoDerivatives 4.0 International. You are free to share, copy and redistribute the material in any medium or format under the following terms:

Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

NonCommercial — You may not use the material for commercial purposes.

NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.

"Non-commercial" means not primarily intended for or directed towards commercial advantage or monetary compensation. The incorporation of publications in commercial products, the use of publications to advertise for commercial products or services and any other usage that directly or indirectly pursues commercial interests is subject to the express previous consent of the publishing house as part of a written agreement.

Please send us your request in writing. Exact indication of the publication from which you would like to reproduce material and detailed information about its intended use help to facilitate and expedite request processing.



Your opinion is important to us

Do not hesitate to contact us: we are looking forward to your comments and suggestions!


Verpassen Sie keinen Artikel!